Navigation Links
Reportlinker Adds The Antibacterials Market Outlook to 2016
Date:5/30/2011

NEW YORK, May 30, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Antibacterials Market Outlook to 2016

http://www.reportlinker.com/p0535949/The-Antibacterials-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Introduction

This report provides comprehensive coverage of the global antibacterials market, incorporating disease overview, epidemiological analyses of the major indications, market dynamics. Resistors and drivers are examined along with the most promising areas of growth. Current leading antibacterial brands are assessed and five of the market's leading players are profiled.

Features and benefits

* Assess the forecast epidemiology and development of the antibacterials market across the 7MM.

* Analyze the dynamics of the global antibacterials market and understand the impact of key R&D events, market trends, and issues.

* Gain up-to-date competitive intelligence and understand the major issues affecting key pharmaceutical marketers and product development.

* Predict revenues for major currently marketed and pipeline antibacterial products over 2010–16

* Develop strategies for success in the future antibacterial market.

Highlights

Of the competing drug classes in global antibacterials market, cephalosporins occupied the leading position with over 25% share followed by penicillins and fluoroquinolones. However, all these drug classes declined in sales in 2010.

Despite high patient numbers, the cost and complexities coupled with regulatory uncertainties and challenges have shifted the investment focus of pharmaceutical manufacturers from antibacterials to treatments for chronic conditions.

Community acquired pneumonia (CAP) and hospital acquired pneumonia (HAP) infections are attracting research interest. Additionally, the majority of companies developing new antibiotics are targeting cell wall synthesis inhibitors, DNA topoisomerase II inhibitors, ribosomal inhibitors and methionine tRNA ligase inhibitors.

Your Key questions answered

* What are the drivers and resistors of the antibacterials market worldwide?

* What market and pipeline developments are shaping the strategies of leading pharmaceutical companies in the antibacterials market?

* What is the forecast commercial potential of the most promising compounds in clinical development?

* Who were the leading players in the global antibacterials market in 2010?

* How have recent launches from companies such as GSK, Pfizer, J&J, Novartis and Merck & Co. performed?

Executive Summary

Disease overview and epidemiology

Global market analysis

Pipeline analysis

Competitive landscape

About the author

Disclaimer

Disease overview and epidemiology

Summary

Introduction

Bacterial infections

Diagnosis, treatment and management

Epidemiology of bacterial infections

Forecast epidemiology

Global market analysis

Summary

Introduction

Market dynamics

Leading brands dynamics

Resistors of the antibacterial market

Drivers of the antibacterial market

Global antibacterial market sales forecast

Pipeline analysis

Summary

Introduction

Antibacterial pipeline

Key events in antibacterial R&D

Cubist settles patent infringement litigation with Teva over Cubicin

Merck & Co. intends to strengthen antibacterial research through BioRelix

GSK exercises its option with Anacor to commercialize GSK2251052

Zeftera withdrawn following concerns raised by the FDA and the EMA

Durata Therapeutics initiates Phase III trials for dalbavancin

Leading drugs in development

Profiles of key pipeline products

Pipeline forecast to 2016

Competitive landscape

Summary

Introduction

GlaxoSmithKline

Overview

Financial performance

Marketed product portfolio

Research and development

Strategic and growth analysis

Pfizer

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Johnson & Johnson

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Merck & Co.

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Novartis

Overview

Financial performance

Marketed product portfolio

Research & development

Strategic and growth analysis

Appendix

Scope

Market size methodology

Epidemiology

Market forecast

Abbreviations

To order this report:

Drug and Medication Industry: The Antibacterials Market Outlook to 2016

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
2. Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016
3. Reportlinker Adds The Infusion Pump Market Outlook to 2016
4. Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook
5. Reportlinker Adds Advances in Drug-Diagnostic Co-Development
6. Reportlinker Adds Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
7. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
8. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
9. Reportlinker Adds Global: Pharmaceuticals Industry Guide
10. Reportlinker Adds Saxagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
11. Reportlinker Adds Generic Pharmaceuticals Industry - Top 200 Generic Pharmaceuticals Industry (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
Breaking Medicine Technology:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
Breaking Medicine News(10 mins):